Jennifer E. Cook Denali Therapeutics Inc. (DNLI) insider trading activity

Jennifer E. Cook is Director of Denali Therapeutics Inc.. Currently has a direct ownership of 26,075 shares of DNLI, which is worth approximately $391,125. The most recent transaction as insider was on Jun 03, 2025, when has been sold 6,037 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 26.1K

30.13% 3M change

30.13% 12M change

Total Value Held $391,125

Jennifer E. Cook Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jun 03 2025	BUY Grant, award, or other acquisition	-	6,037 Added 18.8%	26,075 Common Stock
Jun 06 2024	SELL Open market or private sale	$31,682 $21.73 p/Share	1,458 Reduced 6.78%	20,038 Common Stock
May 31 2024	BUY Grant, award, or other acquisition	-	5,967 Added 21.73%	21,496 Common Stock
Jun 01 2023	BUY Grant, award, or other acquisition	-	4,216 Added 21.35%	15,529 Common Stock
Jun 02 2022	BUY Grant, award, or other acquisition	-	5,986 Added 34.6%	11,313 Common Stock
Jun 02 2021	BUY Grant, award, or other acquisition	-	2,074 Added 28.02%	5,327 Common Stock
Jun 01 2021	BUY Exercise of conversion of derivative security	-	3,253 Added 50.0%	3,253 Common Stock

Also insider at

BBIO

BridgeBio Pharma, Inc. Healthcare

JAZZ

Jazz Pharmaceuticals plc Healthcare

Director

JEC

Jennifer E. Cook

Director

Dublin 4, L2

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells DNLI shares.

Notify only if

Value

Insider Trading

Get notified when an Denali Therapeutics Inc. insider buys or sells DNLI shares.

Notify only if

Operation

Value

Type

News

Receive news related to Denali Therapeutics Inc.

Track Activities on DNLI

Account